StockWatch
·
Pharmaceuticals
Business Update14 Jul 2026, 10:12 am

Ipca Laboratories FY26 Total Income ₹7431.39 Cr

AI Summary

Ipca Laboratories Ltd has filed its Annual Report for the financial year ended March 31, 2026. The report highlights a significant increase in total income, reaching ₹7431.39 Crores, up from ₹6749.21 Crores in the previous fiscal year. Both domestic and export income have shown growth. The company also reported a substantial rise in Net Profit after Tax to ₹1132.52 Crores from ₹650.76 Crores in FY25. Dividend payout has increased to 600% for FY26. The report details the company's financial performance, corporate governance, and sustainability initiatives over the past decade.

Key Highlights

  • Total income for FY26 reached ₹7431.39 Cr, an increase from FY25.
  • Net Profit after Tax surged to ₹1132.52 Cr in FY26.
  • Dividend payout for FY26 stands at a high of 600%.
  • The report covers financial highlights, corporate governance, and sustainability.
  • Both domestic and export revenues have seen positive growth.